Danese, M. D., Gleeson, M. ., Kutikova, L. ., Griffiths, R. I., Azough, A. ., Khunti, K. ., … Ray, K. K. (2016). Estimating the economic burden of cardiovascular events in patients receiving lipid-modifying therapy in the UK. BMJ Open. http://doi.org/10.1136/bmjopen-2016-011805
L. Kutikova
First name
L.
Last name
Kutikova
Danese, M. D., Gleeson, M. ., Griffiths, R. I., Catterick, D. ., & Kutikova, L. . (2017). Methods for estimating costs in patients with hyperlipidemia experiencing their first cardiovascular event in the United Kingdom. J Med Econ. http://doi.org/10.1080/13696998.2017.1345747
Danese, M. D., Gleeson, M. ., Kutikova, L. ., Griffiths, R. I., Khunti, K. ., Seshasai, S. R. K., & Ray, K. K. (2017). Management of lipid-lowering therapy in patients with cardiovascular events in the UK: a retrospective cohort study. BMJ Open. http://doi.org/10.1136/bmjopen-2016-013851
Danese, M. D., Sidelnikov, E. ., & Kutikova, L. . (2018). The prevalence, low-density lipoprotein cholesterol levels, and treatment of patients at very high risk of cardiovascular events in the United Kingdom: a cross-sectional study. Curr Med Res Opin. http://doi.org/10.1080/03007995.2018.1463211
Khunti, K. ., Danese, M. D., Kutikova, L. ., Catterick, D. ., Sorio-Vilela, F. ., Gleeson, M. ., … Ray, K. K. (2018). Association of a Combined Measure of Adherence and Treatment Intensity With Cardiovascular Outcomes in Patients With Atherosclerosis or Other Cardiovascular Risk Factors Treated With Statins and/or Ezetimibe. JAMA Netw Open. http://doi.org/10.1001/jamanetworkopen.2018.5554